Dear Colleague:

Over the six years of organizing the HCA meeting, we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Seventh Annual High-Content Analysis meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, and novel biological models for screening. We will also cover case studies and applications in compound screening, cytotoxicity evaluation, functional analysis, live-cell imaging and more…

HCA 2010 will once again feature a variety of events designed to promote structured networking and brainstorming, including the Advanced Course, panel discussions, and ThinkTank sessions. And of course, we will include a comprehensive tradeshow, co-located user group meetings, technology showcases, and more.

Whether you are an HCA expert or a new adopter, this is the annual event you can't afford to miss!

Julia Boguslavsky
Executive Director, Conferences 
Cambridge Healthtech Institute

HCA 2010 Key Features:

The most comprehensive coverage of high-content analysis applications and technologies:

• Scientific Program features cutting-edge technology and applications presentations from pharma, academia, technology providers and more…
• Unparalleled Networking with the largest gathering of HCA end-users and technology providers at an annual dedicated meeting (400+ delegates in 2009)
• Comprehensive Trade Show offers a one-stop-shop for instrumentation, reagents, and informatics
• Advanced Course offers a perfect format to learn from the experts and brainstorm the practical strategies for HCA implementation, no sales pitches!
• User Group Meetings hosted by leading technology providers
• ThinkTank Sessions allow for brainstorming on key topics with fellow delegates in an informal setting
• New Technology Showcase includes short talks from leading technology providers
• Posters increase the scientific content

Topics Include:

• HCA for Compound Screening
• HCA for In Vitro Toxicology
• HCA for Pathway Analysis and Target Validation
• HCA of GPCRs and Kinases
• Neuronal Screening
• Novel Fluorescent Probes and Biosensors
• Image Analysis and Data Management
• Novel Applications for HCA Technology
• Fluorescence Assays (FLIM, FRET, etc.)
• New Biological Models for HCA
• Live-Cell Imaging
• Label-Free Screening
• Flow Cytometry

Please click here to submit your proposal.  Deadline for submission is Friday, July 10, 2009.

For more information, please contact:
Julia Boguslavsky, Executive Director, Conferences
E-mail: juliab@healthtech.com

For sponsorship information, please contact:
Katelin Fitzgerald, Manager, Business Development
E-mail: kfitzgerald@healthtech.com or Phone: 781-972-5458